Plasma metabolite shows similar performance to CA19-9 in 60-person pancreatic cancer study
An exploratory study of 30 pancreatic cancer patients and 30 healthy controls found similar diagnostic performance for 1,4-dimethylpiperazine and CA19-9, ...
An exploratory study of 30 pancreatic cancer patients and 30 healthy controls found similar diagnostic performance for 1,4-dimethylpiperazine and CA19-9, ...
A systematic network meta-analysis of 185 studies compared 20 blood-based biomarkers for pancreatic cancer, with IMP3 and S100P emerging as ...
Ultra-low-pass whole-genome sequencing of cell-free DNA in bile collected during routine ERCP detected pancreatobiliary cancers with high specificity, identified the ...
Researchers have identified the lipid sphingomyelin (30:1; O2) as a blood-based biomarker that outperforms conventional tumor markers in distinguishing intrahepatic ...
Researchers in China have built a predictive model combining preoperative MRI features and serum CA19-9 levels that accurately identifies pancreatic ...
A Japanese multicenter study of 584 patients has developed a nomogram integrating KRAS mutation status, tumor burden score, nodal metastasis, ...
The PACT-21/CASSANDRA phase 3 trial found that six months of preoperative chemotherapy produced event-free survival comparable to a four-month preoperative ...
Researchers in China have built and validated a predictive model that combines dual-energy CT spectral parameters with clinical indicators to ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine